The Scientist

» clinical trials and developmental biology

Most Recent

image: Unmasking Secret Identities

Unmasking Secret Identities

By | February 1, 2014

A tour of techniques for measuring DNA hydroxymethylation

2 Comments

image: J&J to Share Trial Data

J&J to Share Trial Data

By | January 31, 2014

The pharmaceutical giant teams up with Yale University to make raw clinical data available to researchers.

0 Comments

image: Stem Cell Trials in Peril?

Stem Cell Trials in Peril?

By | January 27, 2014

The only US firm with an ongoing embryonic stem cell therapy clinical trial is in financial and legal hot water.

2 Comments

image: Fish of Many Colors

Fish of Many Colors

By | January 23, 2014

Researchers seek insight into the pigmentation patterns of guppies and zebrafish.

0 Comments

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

image: Next Generation: Cancer Cell Protein Profiling

Next Generation: Cancer Cell Protein Profiling

By | January 15, 2014

Antibody barcoding allows scientists and clinicians to analyze protein expression in small amounts of cancer tissue.

1 Comment

image: Week in Review: January 6–10

Week in Review: January 6–10

By | January 10, 2014

Bacterial genes aid tubeworm settling; pigmentation of ancient reptiles; nascent neurons and vertebrate development; exploring simple synapses; slug-inspired surgical glue

0 Comments

image: UK Government Laments Tamiflu Secrets

UK Government Laments Tamiflu Secrets

By | January 6, 2014

A parliamentary committee says drugmakers have not disclosed enough data on the anti-influenza medicine.

0 Comments

image: Recognizing Basic Science Contributions

Recognizing Basic Science Contributions

By , , and | January 1, 2014

A “basic bibliography” for new drugs would provide scientists with soft incentives and acknowledge the value of basic biomedical research.

4 Comments

image: The Right to Know—or Not

The Right to Know—or Not

By | December 12, 2013

Consumers, patients, and study participants should be made aware of potential incidental findings, according to a federally-appointed bioethics panel.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham